Leila Zegna
Founding Partner @ Kindred Capital
London, United Kingdom
Leila Zegna is a seed investor at Kindred Capital in London focused on Health Care and Artificial Intelligence. Leila co-founded Kindred Capital in March 2015.Kindred aligns their ambitions and achievements with their portfolio. In structure and in spirit. Every entrepreneur Kindred invests in becomes a co-owner of the fund - creating a new category called ‘equitable venture’. Kindred backs companies early and works with the community of founders andadvisers to help founders get further, faster from the very beginning.Prior to setting up Kindred, Leila helped start, advise, and grow start-ups since leaving Bain & Company back in 2007. She has worked with start-ups across 3 continents - Argentina (through the Endeavor network), the UK, and across both coasts of the United States. After earning her MBA from Harvard Business School, Leila moved to Silicon Valley to work in the beating heart of the tech ecosystem. Leila is passionate about supporting women leaders, and specifically finding ways to enable women to work on their own terms - she followed that passion to Plum District (a Kleiner Perkins and General Catalyst backed daily deals company focusing on the mom space) and joined as the General Manager.Leila left Plum District to join the founding team GenapSys, a groundbreaking genomics start-up based in Menlo Park. As the sole business hire for the first 2+ years, Leila was responsible for building the business and operating plans, creating and refining the financial model, and leading the fundraising efforts, successfully raising $50M in venture capital from top investors in seed, Series A, and Series B rounds of financing. The team grew from just a small few to over 50 people under Leila's leadership.Leila has angel investments in 18 early stage companies in both Silicon Valley and the UK, where she now resides. She is an active advisor to several others, and always looking for new ways to engage with and support great founders.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 42%
Last updated:
For AI agents: llms.txt
Industries Leila Zegna invests in
Stages Leila Zegna invests in
Countries Leila Zegna invests in
Round sizes
Round size
- Seed
- $1.5M–$12M
- Series A
- $14M–$24M
- Series B
- $43M–$73M
Investment Focus
Industry
- Health Care 4 (17%)
- Artificial Intelligence 4 (17%)
- Software 3 (13%)
- Biotechnology 3 (13%)
- Information Technology 3 (13%)
Stage
- Seed 11 (46%)
- Series A 5 (21%)
- Series B 5 (21%)
- Series C 2 (8%)
Country
- United States 6 (25%)
- United Kingdom 6 (25%)
- Germany 1 (4%)
- Switzerland 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
RobCo
|
RobCo is a company that develops modular industrial robotics systems combined with AI-driven software to automate manual and repetitive tasks in manufacturing environments. It provides a platform that includes configurable robotic hardware, no-code programming tools, AI-powered vision systems, and digital simulation to plan, test, and deployautomation workflows across applications like machine loading, palletizing, and materials handling. The company’s solutions are designed to be flexible and scalable so manufacturers can adapt robot configurations as production requirements evolve. RobCo also offers tools for remote management, predictive maintenance, and integration with existing equipment to support continuous operation. Its products aim to simplify the adoption of robotics by reducing the need for specialized programming and enabling simulation-based validation before physical deployment. | $100M / Series C / Jan 29, 2026 | |
Audos
|
Audos helps everyday entrepreneurs build small AI companies by providing tools to author AI agents and create businesses around personal interests and experiences. | $11.5M / Seed / Jun 26, 2025 | |
Sohar Health
|
Sohar Health is an AI-driven company that offers front-end Revenue Cycle Management (RCM) solutions. The services focus on enhancing healthcare providers' insurance verification processes, aiming to improve efficiency and reduce claim denials. Sohar Health utilizes advanced technology to streamline eligibility checks and facilitatebetterpricing transparency. The platform caters primarily to the needs of sales teams and sales development representatives in the healthcare sector. By automating key processes, Sohar Health helps organizations optimize their revenue cycle operations. | $3.8M / Seed / Mar 27, 2025 | |
Cradle
|
Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data. | $73M / Series B / Nov 26, 2024 | |
Civic Marketplace
|
Civic Marketplace is a platform that simplifies purchasing decisions, helps agencies make efficient, informed choices, and boosts local economic growth by providing access and opportunities to historically underutilized businesses. | $3.2M / Seed / Nov 20, 2024 | |
LabGenius
|
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. Its protein engineering platform integrates several bleeding-edge technologies from the fields of machine learning, synthetic biology, and robotics. | $44.5M / Series B / May 21, 2024 | |
|
RobCo
|
RobCo is a company that develops modular industrial robotics systems combined with AI-driven software to automate manual and repetitive tasks in manufacturing environments. It provides a platform that includes configurable robotic hardware, no-code programming tools, AI-powered vision systems, and digital simulation to plan, test, and deployautomation workflows across applications like machine loading, palletizing, and materials handling. The company’s solutions are designed to be flexible and scalable so manufacturers can adapt robot configurations as production requirements evolve. RobCo also offers tools for remote management, predictive maintenance, and integration with existing equipment to support continuous operation. Its products aim to simplify the adoption of robotics by reducing the need for specialized programming and enabling simulation-based validation before physical deployment. | $43M / Series B / Feb 26, 2024 | |
|
Cradle
|
Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data. | $24M / Series A / Nov 28, 2023 | |
Sohar Health
|
Sohar Health is a platform for behavioral health companies. It is an API-based solution to handle eligibility verification, and AI-powered medical coding to automate manual workflows, increase patient intake, and generate more revenue | $3.1M / Seed / Sep 29, 2023 | |
|
Sohar Health
|
Sohar Health is a platform for behavioral health companies. It is an API-based solution to handle eligibility verification, and AI-powered medical coding to automate manual workflows, increase patient intake, and generate more revenue | $3.2M / Seed / Sep 29, 2023 | |
| See all 24 investments → | |||
Co-Investors
About Kindred Capital
Kindred is an early stage venture capital fund based in London that practices equitable venture. Kindred aligns ambitions and achievements with the portfolio. In structure and in spirit. Every single founder that the company backs will become a co-owner of the fund.
Kindred Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chrysanthos Chrysanthou
Partner
|
|||
|
Leila Zegna
Founding Partner
|
|||
Andrew Baldwin
Finance & Operations Lead
|
|||
John Cassidy
Partner
|
|||
Karen Swain
CFO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Leila Zegna invest in?
Leila Zegna invests primarily in Health Care, Artificial Intelligence and Software startups, most often at Seed and Series A stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Leila Zegna's check size?
Leila Zegna typically joins rounds of $1.5M–$12M at Seed, $14M–$24M at Series A and $43M–$73M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Leila Zegna participates in.
When did Leila Zegna last invest?
The most recent investment recorded for Leila Zegna closed in Jan 2026. Shizune tracks 24 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
